Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,398,734 papers from all fields of science
Search
Sign In
Create Free Account
DuP 654
Known as:
DuP-654
, DuP654
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
2-(phenylmethyl)-1-naphthol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II.
P. Arenberger
,
A. Raap
,
B. Armah
,
L. Kemény
,
T. Ruzicka
Skin Pharmacology
1993
Corpus ID: 44343961
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) has been shown to be an active anti-inflammatory drug in a murine…
Expand
1992
1992
An evaluation of 2-benzyl-1-naphthol (DuP 654) analogs as systemic anti-inflammatory agents.
J. Kerr
,
D. Batt
,
D. Pinto
,
H. Stampfli
Research communications in chemical pathology and…
1992
Corpus ID: 45041173
DuP 654 (2-benzyl-1-naphthol) is a topically active anti-inflammatory agent that was evaluated in phase II clinical trials as an…
Expand
1990
1990
Cellular and biochemical characterization of the anti-inflammatory effects of DuP 654 in the arachidonic acid murine skin inflammation model.
R. Harris
,
W. Mackin
,
+4 authors
N. Ackerman
Skin Pharmacology
1990
Corpus ID: 22358296
The possible utility of DuP 654, a potent 5-lipoxygenase inhibitor, for treating human inflammatory skin disease was investigated…
Expand
1989
1989
Topical anti-inflammatory activity of DuP 654, a 2-substituted 1-naphthol
R. Harris
,
D. Batt
,
W. Galbraith
,
N. Ackerman
Agents and Actions
1989
Corpus ID: 5665253
Recent work suggests that one of the common biochemical characteristics of skin inflammatory diseases such as psoriasis is…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE